View in EDS HTML Full Text PDF Full Text

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Saved in:
Bibliographic Details
Title: Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.
Authors: Hatanaka, Takeshi1 (AUTHOR), Yata, Yutaka2 (AUTHOR) yu‐yata@maebashi.saiseikai.or.jp, Hiraoka, Atsushi3 (AUTHOR), Tada, Toshifumi4 (AUTHOR), Hirooka, Masashi5 (AUTHOR), Kariyama, Kazuya6 (AUTHOR), Tani, Joji7 (AUTHOR), Atsukawa, Masanori8 (AUTHOR), Takaguchi, Koichi9 (AUTHOR), Itobayashi, Ei10 (AUTHOR), Kakizaki, Satoru11,12 (AUTHOR), Fukunishi, Shinya13 (AUTHOR), Tsuji, Kunihiko14 (AUTHOR), Ishikawa, Toru15 (AUTHOR), Tajiri, Kazuto16 (AUTHOR), Toyoda, Hidenori17 (AUTHOR), Koshiyama, Yuichi17 (AUTHOR), Ogawa, Chikara18 (AUTHOR), Nishikawa, Hiroki19 (AUTHOR), Nishimura, Takashi13 (AUTHOR)
Source: Liver International. Jul2025, Vol. 45 Issue 7, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.70192